Literature DB >> 8103909

Regulatory role of enteric kappa opioid receptors in human colonic motility.

P Chamouard1, A Klein, E Martin, M Adloff, F Angel.   

Abstract

The effects of different kappa opioid agonists and antagonists on spontaneous mechanical activities and responses to electrical transmural nerve stimulation of both longitudinal and circular muscle strips from the human sigmoid colon were studied. A superfusion apparatus was used to record isometric contractions. Exogenously added kappa agonists did not modify spontaneous contractile activities on either type of strip. Nerve stimulation induced a triphasic response composed of a first contraction (C1) followed by a relaxation (C2) and an off-contraction (C3); this response was mediated by cholinergic excitatory nerves and non-adrenergic, non-cholinergic excitatory and inhibitory nerves. Dynorphin 1-13 and the synthetic kappa agonist trans-3,4-dichloro-N-methyl-N-(2- [1pyrolidinyl]-cyclohexyl) dramatically decreased the amplitude of the excitatory components C1 and C3. The effects of both kappa agonists were blocked in presence of the kappa antagonist Nor-Binaltorphimine. The delta antagonist ICI 174864 did not prevent the inhibition of the contractions C1 and C3 induced by dynorphin. Therefore, these data suggest that kappa receptors are involved in the neuroregulation of smooth muscle of human colon and mediate inhibition of cholinergic and non-cholinergic excitatory transmission within myenteric plexus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103909     DOI: 10.1016/0024-3205(93)90551-d

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Morphology of enkephalin-immunoreactive myenteric neurons in the human gut.

Authors:  A Brehmer; T M Lindig; F Schrödl; W Neuhuber; D Ditterich; M Rexer; H Rupprecht
Journal:  Histochem Cell Biol       Date:  2005-03-18       Impact factor: 4.304

2.  Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.

Authors:  Anaid Shahbazian; Akos Heinemann; Helmut Schmidhammer; Eckhard Beubler; Ulrike Holzer-Petsche; Peter Holzer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.

Authors:  Allen W Mangel; Gareth A Hicks
Journal:  Clin Exp Gastroenterol       Date:  2012-01-12

4.  Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design.

Authors:  John Broad; Damien Maurel; Victor W S Kung; Gareth A Hicks; Michael Schemann; Michael R Barnes; Terrence P Kenakin; Sébastien Granier; Gareth J Sanger
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

5.  Pain or constipation: A difficult choice.

Authors:  Trikha Anjan; Pm Singh
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-10

Review 6.  The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review.

Authors:  MahmoudReza Khansari; MasourReza Sohrabi; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2013-01

7.  Divergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats.

Authors:  Xiaocui Bian; Renlong Zhou; Yuting Yang; Peiying Li; Yannan Hang; Youmin Hu; Liqun Yang; Daxiang Wen
Journal:  Int J Med Sci       Date:  2015-10-15       Impact factor: 3.738

Review 8.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

Review 9.  Opioids in cancer: The κ‑opioid receptor (Review).

Authors:  Qier Zhou; Zhiwei Zhang; Songkai Long; Wanjun Li; Baiyun Wang; Na Liang
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.